Larvol Delta - Obexelimab-Reduced-GlucocorticoidAssociated-Toxicity-in-Patients-With-IgG4Related-Disease-Results-From-the-Phase-3-Randomized-PlaceboControlled-Indigo-Trial

Saphnelo (anifrolumab-fnia) - AstraZeneca

https://acrconvergence2026.eventscribe.net/fsPopup.asp?PresentationID=1896620&mode=presInfo

Rochelle Castillo, MD

Sep 8, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next